Cagrilintide and tirzepatide are discussed together because both are once-weekly injectables that reduce appetite and bodyweight, and both slow gastric emptying as part of that effect
Individual results may vary, and not all treatments discussed are appropriate for all individuals
My personal hypothesis is that contrary to what Lilly is saying with dose anytime with no special instructions, Id bet a fair sum of money that taking orforglipron with a snack at the same time each day would lead to dramatically better tolerability
Heart rate: the escalation transient This is the two-instruments effect covered above: a modest chronic mean, a larger escalation peak, and a lean, East-Asian tail. Blood pressure moves the other way, down about 6 to 9 mmHg systolic, so the heart-rate rise is not a blood-pressure effect, and it reverses when the drug stops. Low blood sugar tracks the insulin background On its own tirzepatide is insulin-sparing and rarely causes low blood sugar
Yes, as a general rule of thumb, most oral peptides benefit from being taken on an empty stomach